Seung Lee, MD
Pain Medicine · Baltimore, MDNPI 1396935961
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Tersera Therapeutics LLC at 27.7% of the total. Reporting peaked in 2019 at $139 and has fallen 60.7% since, to $54 in 2021. That places this record below the midpoint for pain medicine clinicians in MD, where the typical reported total is $1,479.
Across 14 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tersera Therapeutics LLC$72
- AbbVie$68
- Nevro Corp.$53
- SPR Therapeutics, Inc$27
- Boston Scientific$23
- Medtronic$16
Across 72 payments — averaging $9439.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$570K
- Beone Medicines USA, Inc.$73K
- AstraZeneca$36K
What the payments were for
- Food & beverage$258100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tersera Therapeutics LLC | 4 | $72 |
| AbbVie(2 entities) | 3 | $68 |
| Nevro Corp. | 3 | $53 |
| SPR Therapeutics, Inc | 2 | $27 |
| Boston Scientific | 1 | $23 |
| Medtronic | 1 | $16 |
How this compares
$258 in reported general payments places this provider in the 20th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 197 | $3,383 |
| Xtampza ErOxycodone Myristate | 14 | $3,020 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 56 | $2,838 |
| Pregabalin | 64 | $2,225 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $1,665 |
| Baclofen | 33 | $1,124 |
| Naloxone Hcl | 12 | $839 |
| Duloxetine Hcl | 33 | $823 |
| Lidocaine | 14 | $816 |
| Morphine Sulfate ErMorphine Sulfate | 40 | $812 |
| Gabapentin | 59 | $567 |
| Tizanidine Hcl | 31 | $528 |
| Cyclobenzaprine Hcl | 31 | $483 |
| Tramadol Hcl | 31 | $397 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 20 | $224 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Baltimore
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Behnam JafarpourBaltimore$45K
- David MaineBaltimore$24K
- Jay KarriBaltimore$14K
- Avni GuptaBaltimore$12K
- Anuragh TrikhaBaltimore$9K
- Brian BlockBaltimore$7K
- Benjamin Fujita-HowieBaltimore$6K
- William RaoofiBaltimore$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.